Weight Loss
Tirzepatide Semaglutide
Compare

Wegovy Alternatives: Compounded Semaglutide Online

How brand-name Wegovy compares with provider-prescribed compounded semaglutide — and the other GLP-1 options worth knowing.

Updated November 2, 20266 min readWritten to help you talk to a licensed provider

Wegovy (semaglutide) is one of the most effective FDA-approved weight-management medications available, but its list price and insurance hurdles put it out of reach for many people. If you have been priced out of Wegovy or cannot get it covered, you have options worth understanding before you give up on GLP-1 therapy.

This guide compares Wegovy with the main alternatives — including provider-prescribed compounded semaglutide, compounded tirzepatide, and lifestyle-first approaches — so you can have an informed conversation with a licensed provider about what fits your situation.

What is Wegovy?

Wegovy is a brand-name, once-weekly injectable from Novo Nordisk. Its active ingredient, semaglutide, is a GLP-1 receptor agonist that helps regulate appetite and blood sugar. It is FDA-approved for chronic weight management in eligible adults and adolescents, typically alongside diet and physical activity.

Why people look for a Wegovy alternative

  • Cost: Wegovy’s list price is roughly $1,300+ per month, and many insurance plans exclude weight-loss drugs.
  • Access: supply and pharmacy availability have been inconsistent, and prior authorizations can take weeks.
  • Fit: some people tolerate a different molecule (such as tirzepatide) better, or prefer a provider who manages dosing and side effects closely.

Wegovy vs. compounded semaglutide

Brand-name WegovyZENKAI compounded semaglutide
Active ingredientSemaglutideSemaglutide
FDA statusFDA-approvedCompounded; not FDA-approved
Typical cost~$1,300+/mo list priceFrom $199/mo, cash-pay
InsuranceSometimes covered (often excluded)No insurance required
How you get itPrescription at a retail pharmacyProvider consult online, shipped to your door
Provider oversightYesYes — US-licensed provider reviews every case

About compounded medications

Compounded semaglutide and tirzepatide are prepared by state-licensed 503A compounding pharmacies for an individual patient after a provider consultation. They are not FDA-approved products, are not reviewed by the FDA for safety or effectiveness, and are only appropriate when a licensed provider determines they are clinically suitable for you.

Other alternatives to consider

Compounded tirzepatide is a dual GLP-1/GIP option that some patients find effective; it is the compounded counterpart to brand-name Zepbound and Mounjaro. Oral semaglutide and non-GLP-1 medications exist as well, and for some people a structured nutrition and activity program is the right first step. A licensed provider can help you weigh these against your medical history.

How ZENKAI works

You complete a medical intake online, a US-licensed provider reviews your history and goals, and — if a GLP-1 is appropriate for you — your prescription is prepared by a state-licensed 503A pharmacy and shipped cold-chain to your door. Pricing is transparent and cash-pay, with no insurance battles. Treatment and prescribing decisions are made independently by the provider, not by ZENKAI.

See if a GLP-1 is right for you

Complete a short online intake. A US-licensed provider reviews your history and goals — no insurance required.

Start your free assessment
Compounded medications are not FDA-approved. Prescribing decisions are made independently by licensed providers.

Frequently asked questions

Is compounded semaglutide the same as Wegovy?

Both use the active ingredient semaglutide, but they are not the same product. Wegovy is an FDA-approved, branded medication. Compounded semaglutide is prepared by a licensed 503A pharmacy for an individual patient and is not FDA-approved. Only a licensed provider can decide whether it is appropriate for you.

How much does a Wegovy alternative cost?

Brand-name Wegovy commonly lists around $1,300+ per month before insurance. ZENKAI’s provider-prescribed compounded semaglutide starts at $199/month cash-pay, with physician review and shipping included. Prices and availability change, so confirm current figures during your consultation.

Do I need insurance?

No. ZENKAI programs are cash-pay, with no insurance, prior authorizations, or pharmacy back-and-forth required.

Is a Wegovy alternative right for me?

That depends on your medical history, goals, and tolerance. A licensed provider reviews your intake and recommends an approach — which may or may not include a GLP-1 medication.

This page is for general education and is not medical advice. It does not establish a provider-patient relationship. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A pharmacies, are not FDA-approved, and are only appropriate when a licensed provider determines they are suitable for you. Prescribing and treatment decisions are made independently by licensed providers. Results vary.